Generate Biomedicines, Inc. carries a market capitalization of 1.84B, placing it among publicly traded companies globally.
| Market Cap | 1.84B |
| Enterprise Value | N/A |
Generate Biomedicines, Inc.'s stock has gained approximately 13.75494% over the past 52 weeks. The 50-day moving average sits at 14.42, while the 200-day moving average is 13.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.75494% |
| 50-Day Moving Average | 14.42 |
| 200-Day Moving Average | 13.50 |
| Average Volume (20 Days) | N/A |